Fonte: Journal of Biotechnology and Biomaterials. Nome do evento: Global Congress on Biotechnology. Unidade: FCF
ABNT
COSTA-SILVA, Tales Alexandre et al. Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment. Journal of Biotechnology and Biomaterials. Sunnyvale: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.4172/2155-952X-C2-116. Acesso em: 03 nov. 2024. , 2019APA
Costa-Silva, T. A., Costa, I. M., Agamez-Montalvo, G. S., Pessoa Junior, A., & Monteiro, G. (2019). Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment. Journal of Biotechnology and Biomaterials. Sunnyvale: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.4172/2155-952X-C2-116NLM
Costa-Silva TA, Costa IM, Agamez-Montalvo GS, Pessoa Junior A, Monteiro G. Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment [Internet]. Journal of Biotechnology and Biomaterials. 2019 ; 9 58.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/2155-952X-C2-116Vancouver
Costa-Silva TA, Costa IM, Agamez-Montalvo GS, Pessoa Junior A, Monteiro G. Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment [Internet]. Journal of Biotechnology and Biomaterials. 2019 ; 9 58.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/2155-952X-C2-116